Current portfolio

Nkarta

US biotech company developing engineered natural killer (NK) cell therapies

  • Sector
    Healthcare
  • Country
    United States
  • Fund
    LSP 6
  • Entry
    2019
  • Web
    nkartatx.com
Nkarta
0
Investments
EQT logo